Published in Am J Pathol on November 01, 1999
On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited. Eur Thyroid J (2016) 1.04
Revising the embryonic origin of thyroid C cells in mice and humans. Development (2015) 0.88
A unique RET EXON 11 (G691S) polymorphism in an Indian patient with a collision tumor of the thyroid. Diagn Pathol (2007) 0.82
Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue. Br J Cancer (2002) 0.81
Mixed medullary-follicular carcinoma of the thyroid. Case Rep Endocrinol (2013) 0.75
Genetic instabilities in human cancers. Nature (1998) 22.76
Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet (1992) 11.38
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (1993) 5.81
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet (1993) 4.38
Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res (1987) 4.25
Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. J Clin Endocrinol Metab (1959) 4.08
Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol (1996) 2.20
Solid cell nests of the thyroid: light microscopy and immunohistochemical profile. Hum Pathol (1994) 2.13
Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med (1996) 2.05
C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med (1973) 1.95
C-cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto's thyroiditis. Am J Surg Pathol (1989) 1.60
Histogenesis of medullary carcinoma of the thyroid. J Clin Pathol (1966) 1.57
Methylation patterns at the hypervariable X-chromosome locus DXS255 (M27 beta): correlation with X-inactivation status. Genomics (1990) 1.57
Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma". Am J Surg Pathol (1984) 1.57
Use of genetic markers to study cellular origin and development of tumors in human females. Adv Cancer Res (1972) 1.46
Mucosubstances in medullary carcinoma of the thyroid. Histopathology (1988) 1.43
Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol (1987) 1.33
Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf) (1996) 1.31
Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Hum Pathol (1998) 1.18
Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol (1996) 1.18
Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am J Pathol (1999) 1.10
Concurrence of a symptomatic encapsulated follicular carcinoma, an occult papillary carcinoma and a medullary carcinoma in the same patient. Histopathology (1992) 1.08
Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Cancer (1995) 1.03
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab (1996) 1.02
Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases. J Pathol (1999) 1.01
The ultimobranchial gland and congenital thyroid abnormalities in man. J Pathol (1989) 1.00
Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am J Clin Pathol (1996) 0.95
Mechanisms of nonneoplastic endocrine hyperplasia--a changing concept: a review focused on the thyroid gland. Endocr Rev (1995) 0.94
Genetic alterations in human epithelial thyroid tumours. Clin Endocrinol (Oxf) (1998) 0.94
C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol (1988) 0.93
Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res (1996) 0.92
A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity? Cancer (1983) 0.92
Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma. J Clin Endocrinol Metab (1998) 0.91
Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol (1980) 0.91
Calcitonin free oat-cell carcinoma of the thyroid gland. Virchows Arch A Pathol Anat Histopathol (1990) 0.90
Clonal analysis of solitary follicular nodules in the thyroid. Am J Pathol (1990) 0.90
Coexistence of papillary and medullary carcinoma of the thyroid gland-mixed or collision tumour? Clinicopathological analysis of three cases. Virchows Arch (1994) 0.89
Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity? Lab Invest (1987) 0.88
Medullary and papillary carcinomas occurring as a collision tumor: report of a case. Clin Nucl Med (1989) 0.87
Mixed medullary-papillary carcinoma of the thyroid: a previously unrecognized variant of thyroid carcinoma. Hum Pathol (1990) 0.87
Clonality of thyroid nodules in sporadic goiter. Diagn Mol Pathol (1995) 0.87
Compound medullary-papillary carcinoma of the thyroid: true mixed versus collision tumour [corrected]. Histopathology (1994) 0.87
Carcinoma of the thyroid with a mixed medullary and follicular pattern: morphologic, immunohistochemical, and clinical laboratory studies. Cancer (1982) 0.86
Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma. Mod Pathol (1996) 0.86
Differentiated thyroid carcinoma, intermediate type: a new tumor entity with features of follicular and parafollicular cell carcinoma. Hum Pathol (1984) 0.86
RET protooncogene analysis in the diagnosis of medullary thyroid carcinoma and multiple endocrine neoplasia type II. Adv Anat Pathol (1998) 0.85
Concurrent medullary and papillary thyroid carcinoma in the same thyroid lobe and in siblings. Acta Med Scand (1981) 0.85
Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases. Virchows Arch (1997) 0.84
Medullary carcinoma. Semin Diagn Pathol (1985) 0.84
Thyroglobulin in medullary thyroid carcinoma: immunohistochemical study with polyclonal and monoclonal antibodies. Hum Pathol (1993) 0.83
Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma. Thyroid (1991) 0.83
Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab (1994) 0.82
Polyclonal origin of medullary carcinoma of the thyroid in multiple endocrine neoplasia type 2. Hum Genet (1997) 0.82
Medullary (C cell) carcinoma of the thyroid with features of follicular oxyphilic cell tumours. Histopathology (1988) 0.82
C cell carcinoma of the thyroid--papillary type. Acta Pathol Jpn (1979) 0.82
Glandular (tubular and follicular) variants of medullary carcinoma of the thyroid. Histopathology (1983) 0.81
Clear cell variant of medullary carcinoma of the thyroid. Hum Pathol (1985) 0.81
Oxyphil and squamous variants of medullary thyroid carcinoma. Cancer (1989) 0.81
Mixed medullary and follicular carcinoma of the thyroid. Virchows Arch A Pathol Anat Histopathol (1983) 0.81
Hyalinizing trabecular carcinoma of the thyroid gland. Hum Pathol (1994) 0.81
Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues. Diagn Mol Pathol (1996) 0.80
The site of leakage of intrafollicular thyroglobulin into the blood stream in simple human goiter. J Clin Endocrinol Metab (1983) 0.80
Carcinoma of the thyroid with a mixed medullary, papillary, follicular, and undifferentiated pattern. Arch Intern Med (1985) 0.80
Mixed medullary-follicular thyroid carcinoma. Am J Surg Pathol (1986) 0.79
Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation. J Invest Dermatol (1998) 0.79
Immunofluorescent localisation of calcitonin in medullary C-cell thyroid carcinoma, using antibody to the pure porcine hormone. Virchows Arch B Cell Pathol (1969) 0.79
Mixed medullary-follicular carcinoma of the thyroid occurring in familial form. Histopathology (1993) 0.78
Molecular analysis of synchronous uterine and ovarian endometrioid tumors. Int J Gynecol Pathol (1997) 0.78
Mixed medullary and follicular carcinoma of the thyroid. Histopathology (1993) 0.78
Simultaneous occurrence of medullary carcinoma and papillary carcinoma of the thyroid. J Surg Oncol (1995) 0.78
Lectin histochemistry and ultrastructure of medullary carcinoma of the thyroid gland. Arch Pathol Lab Med (1990) 0.78
Renal Cell Carcinoma Metastatic to the Thyroid Gland: A Comparative Molecular Study Between the Primary and the Metastatic Tumor. Endocr Pathol (1998) 0.76
Mixed thyroid carcinoma: a real entity? Lab Invest (1987) 0.76
Sustentacular cells occur frequently in the familial form of medullary thyroid carcinoma. J Pathol (1998) 0.76
Expression of the ret proto-oncogene in phaeochromocytoma. An in situ hybridization and northern blot study. J Pathol (1995) 0.76
Surface features in human thyroid disorders. A scanning electron microscopic study of ninety five cases. J Submicrosc Cytol (1982) 0.76
Calcitonin and carcinoembryonic antigen in poorly differentiated follicular carcinoma. Cancer (1982) 0.76
Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma. Hum Mutat (1997) 0.76
Identification of the same HRAS1 mutation in a primary minimally invasive follicular carcinoma of the thyroid gland and its bone metastasis developed 15 years later. Diagn Mol Pathol (1995) 0.76
Mutational heterogeneity among individual tumors in a case of multiple primary malignancy of the colon. Jpn J Clin Oncol (1993) 0.76